Additionally, the study demonstrated that elevated expression of Secreted Protein Acidic and Rich in Cysteine (SPARC) in the tumor stroma is associated with improved survival rates, supporting the hypothesis that targeting stromal components is essential for maximizing treatment efficacy. The gene discussed is SPARC; the disease is neoplasm.